D.E. Shaw & Co
GH icon

D.E. Shaw & Co’s Guardant Health GH Stock Holding History

D.E. Shaw & Co’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.47M Buy
+15,900
New +$1.6M ﹤0.01% 3154
2025
Q1 		– Sell
-14,700
Closed -$449K – 4458
2024
Q4 		$449K Sell
14,700
-2,200
-13% -$61.9K ﹤0.01% 3681
2024
Q3 		$388K Hold
16,900
– – ﹤0.01% 3844
2024
Q2 		$488K Hold
16,900
– – ﹤0.01% 3637
2024
Q1 		$349K Buy
+16,900
New +$362K ﹤0.01% 3663
2023
Q3 		– Sell
-11,800
Closed -$422K – 4358
2023
Q2 		$422K Buy
+11,800
New +$339K ﹤0.01% 3486

Other funds holding GH

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return